• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫显性:抗原位点内的单个氨基酸取代改变了T细胞决定簇的分子内选择。

Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants.

作者信息

Liu Z, Williams K P, Chang Y H, Smith J A

机构信息

Department of Molecular Biology, Massachusetts General Hospital, Boston.

出版信息

J Immunol. 1993 Aug 15;151(4):1852-8.

PMID:7688387
Abstract

The mechanism of immunodominance was studied by mutating a single amino acid residue within an immunodominant determinant of Staphylococcus aureus nuclease (Nase). Residues 81 to 100, which can be further reduced to 86 to 100, were determined to be the immunodominant determinant of Nase in H-2k mice. By introducing selected single amino acid substitutions into the peptide encompassing residues 86 to 100 (p86-100), residue 90 was shown to be one of the critical amino acids for T cell recognition, inasmuch as most of the T cells recognizing p86-100 do not respond to a p86-100 analog with a substitution of leucine for alanine at the residue 90. A mutant of Nase with a replacement of alanine by leucine at residue 90 (A90L) was constructed, and for A90L region 112 to 130, which is a subdominant determinant in Nase, becomes immunodominant. Although unable to respond to Nase, T cells primed in vivo with the peptides covering various cryptic determinants proliferate when challenged with A90L in vitro. Our results suggest that at the protein level there is competition among potential T cell determinants of protein Ag for binding to MHC molecules, and that this competition plays a role in determining which determinant may become immunodominant.

摘要

通过对金黄色葡萄球菌核酸酶(Nase)免疫显性决定簇内的单个氨基酸残基进行突变,研究了免疫显性机制。已确定81至100位残基(可进一步缩减为86至100位残基)是H-2k小鼠中Nase的免疫显性决定簇。通过将选定的单个氨基酸取代引入包含86至100位残基的肽(p86-100)中,发现90位残基是T细胞识别的关键氨基酸之一,因为大多数识别p86-100的T细胞对90位残基处亮氨酸取代丙氨酸的p86-100类似物无反应。构建了90位残基处丙氨酸被亮氨酸取代的Nase突变体(A90L),对于A90L,Nase中的次显性决定簇112至130区域变得具有免疫显性。尽管无法对Nase作出反应,但用覆盖各种隐蔽决定簇的肽在体内引发的T细胞在体外受到A90L刺激时会增殖。我们的结果表明,在蛋白质水平上,蛋白质抗原潜在的T细胞决定簇之间存在竞争以结合MHC分子,并且这种竞争在决定哪个决定簇可能成为免疫显性方面起作用。

相似文献

1
Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants.免疫显性:抗原位点内的单个氨基酸取代改变了T细胞决定簇的分子内选择。
J Immunol. 1993 Aug 15;151(4):1852-8.
2
Single amino acid substitution alters T cell determinant selection during antigen processing of Staphylococcus aureus nuclease.单个氨基酸取代改变了金黄色葡萄球菌核酸酶抗原加工过程中的T细胞决定簇选择。
J Immunol. 1991 Jan 15;146(2):438-43.
3
Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo.干扰天然加工的肽与II类分子的结合会改变体内T细胞表位的免疫显性。
J Immunol. 1994 Aug 1;153(3):1015-26.
4
Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones.最小免疫显性位点之外的序列对葡萄球菌核酸酶特异性T细胞克隆的识别产生负面影响。
J Immunol. 1989 Nov 1;143(9):2814-9.
5
Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.乙肝核心抗原(HBcAg)T细胞决定簇中免疫原性与耐受性的区分。肽-主要组织相容性复合体(peptide-MHC)相互作用的影响。
J Immunol. 1989 Nov 15;143(10):3148-56.
6
The immunodominant region of Staphylococcal nuclease is represented by multiple peptide sequences.葡萄球菌核酸酶的免疫显性区域由多个肽序列代表。
Cell Immunol. 1996 Sep 15;172(2):254-61. doi: 10.1006/cimm.1996.0240.
7
Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.分枝杆菌T细胞表位的允许性识别:与多个主要组织相容性复合体II类I-A分子相关识别的重叠表位核心序列的定位
Immunology. 1995 Apr;84(4):555-61.
8
Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease.与T细胞介导的寄生虫病相关的免疫显性肽关键残基的阐释及其作用
J Immunol. 1999 Oct 1;163(7):3877-82.
9
Immunodominance does not result from peptide competition for MHC class II presentation.免疫显性并非由肽段对MHC II类分子提呈的竞争所致。
J Immunol. 1998 Feb 15;160(4):1759-66.
10
The T cell repertoire for recognition of a phylogenetically distant protein antigen. Peptide specificity and MHC restriction of staphylococcal nuclease-specific T cell clones.用于识别系统发育上远缘蛋白质抗原的T细胞库。葡萄球菌核酸酶特异性T细胞克隆的肽特异性和MHC限制。
J Exp Med. 1986 Sep 1;164(3):897-910. doi: 10.1084/jem.164.3.897.

引用本文的文献

1
Rational immunosilencing of a promiscuous T-cell epitope in the capsid of an adeno-associated virus.理性免疫沉默腺相关病毒衣壳中一种混杂 T 细胞表位。
Nat Biomed Eng. 2024 Feb;8(2):193-200. doi: 10.1038/s41551-023-01129-8. Epub 2023 Nov 23.
2
Anti-Leishmanial Vaccines: Assumptions, Approaches, and Annulments.抗利什曼原虫疫苗:假设、方法与废止
Vaccines (Basel). 2019 Oct 18;7(4):156. doi: 10.3390/vaccines7040156.
3
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors.
具有T细胞表位突变的重组免疫毒素,可大大降低免疫原性,用于治疗表达间皮素的肿瘤。
Mol Cancer Ther. 2015 Dec;14(12):2789-96. doi: 10.1158/1535-7163.MCT-15-0532. Epub 2015 Oct 6.
4
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes.通过鉴定和沉默人 T 细胞表位降低免疫原性的用于癌症治疗的重组免疫毒素。
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8571-6. doi: 10.1073/pnas.1405153111. Epub 2014 May 5.
5
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin A.基于绿脓杆菌外毒素 A 的重组免疫毒素中免疫优势 T 细胞表位的鉴定和消除。
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):E3597-603. doi: 10.1073/pnas.1218138109. Epub 2012 Dec 3.
6
Understanding the focused CD4 T cell response to antigen and pathogenic organisms.理解针对抗原和病原体的聚焦 CD4 T 细胞反应。
Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7.
7
Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.CD4 T细胞对外源抗原的免疫显性是肽段内在的,且独立于分子背景:对疫苗设计的启示。
J Immunol. 2008 Sep 1;181(5):3039-48. doi: 10.4049/jimmunol.181.5.3039.
8
Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains.I类主要组织相容性复合体(MHC)对复合免疫原性表位和自身表位的同种嵌合呈递可诱导对基因不同的大鼠品系产生耐受性。
Cell Immunol. 2007 Jul;248(1):48-58. doi: 10.1016/j.cellimm.2007.04.008. Epub 2007 Oct 23.
9
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.在乙肝病毒感染中血清转化为抗-HBe和抗-HBs期间,异质性乙肝核心抗原和e抗原特异性CD4+ T细胞群体的激活。
J Virol. 1995 Jun;69(6):3358-68. doi: 10.1128/JVI.69.6.3358-3368.1995.